Paula Stoddard
Primary Care · Hanford, CANPI 1164007118
Payments from drug & device makers
Across 572 payments — averaging $38.18 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Galderma Laboratories, L.p.$14K
- AbbVie$2K
- E.r. Squibb & Sons, L.L.C.$1K
- Incyte Corporation$605
- Johnson & Johnson$563
- UCB, Inc.$540
- plus $2K from 19 others
What the payments were for
- Speaking & faculty fees$12,90059%
- Travel & lodging$1751%
- Food & beverage$8,41739%
- Education$3462%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Galderma Laboratories, L.p. | 108 | $14,243 |
| AbbVie | 148 | $2,307 |
| E.r. Squibb & Sons, L.L.C. | 94 | $1,085 |
| Incyte Corporation | 34 | $605 |
| Johnson & Johnson | 27 | $563 |
| UCB, Inc. | 31 | $540 |
| Sanofi | 19 | $461 |
| Regeneron Healthcare Solutions, Inc. | 13 | $298 |
| Novartis | 12 | $288 |
| Dermavant Sciences, Inc. | 21 | $246 |
| Sun Pharmaceutical Industries Inc. | 10 | $226 |
| LEO Pharma Inc. | 9 | $174 |
| Pfizer | 14 | $169 |
| Lilly USA, LLC | 7 | $147 |
| Amgen | 7 | $117 |
| Sanofi-aventis U.S. LLC | 1 | $80 |
| Arcutis Biotherapeutics, Inc. | 4 | $59 |
| Esperion Therapeutics, Inc. | 1 | $49 |
| Organon | 6 | $39 |
| Krystal Biotech Inc | 1 | $30 |
| LNHC, Inc | 1 | $26 |
| Ortho Dermatologics, A Division Of Bausch Health US, LLC | 1 | $25 |
| ANI Pharmaceuticals, Inc. | 1 | $21 |
| VYNE Pharmaceuticals Inc. | 1 | $20 |
| Journey Medical Corporation | 1 | $18 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$21,838 in reported general payments places this provider in the 95th percentile of 706 primary care providers in California.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Clobetasol Propionate | 123 | $5,000 |
| Clindamycin Phosphate | 45 | $1,981 |
| Ketoconazole | 133 | $1,931 |
| Fluocinolone Acetonide | 34 | $1,734 |
| Triamcinolone Acetonide | 124 | $1,112 |
| Mupirocin | 88 | $830 |
| CiclopiroxCiclopirox Olamine | 11 | $808 |
| Doxycycline Hyclate | 23 | $801 |
| Metronidazole | 13 | $692 |
| Betamethasone Dipropionate | 16 | $644 |
| Ciclopirox | 13 | $556 |
| Spironolactone | 41 | $419 |
| ValacyclovirValacyclovir Hcl | 22 | $380 |
| Nystatin | 11 | $264 |
| Prednisone | 12 | $29 |
Paid to pharmacies, not to this prescriber.
Other primary care in Hanford
- Leslie FletcherTorrance$1.8M
- Hamideh PourzandLos Angeles$103K
- Veronica RamirezSacramento$83K
- Tyson FieldstedBakersfield$65K
- Joann BallPalm Desert$56K
- Kathryn CooperSan Diego$31K
- Shalaine Corbillala Mesa$22K
- Ashley LoweSan Diego$19K
- Vanessa LeeLong Beach$16K
- Lynda TranHuntington Beach$16K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.